Citations Report

Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.

Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.

Alonso-Vega, Jesús, Miguel Núñez de Prado-Gordillo, Gladis Lee Pereira, and María Xesús Froján-Parga. "El tratamiento de Enfermedades Mentales Graves desde la investigación de procesos." (2019): 44-65.

Brookman, Fiona, and Trevor H. Bennett. "Fighting like M-Cats and dogs: Users’ accounts of the links between mephedrone use and violence." European Journal of Criminology 15, no. 2 (2018): 151-171.

Leyrer?Jackson, Jonna M., and Mark P. Thomas. "Subtype?specific effects of dopaminergic D2 receptor activation on synaptic trains in layer V pyramidal neurons in the mouse prefrontal cortex." Physiological reports 5, no. 22 (2017): e13499.

Thorstensen, Jacob R., Murray G. Tucker, and Justin J. Kavanagh. "Antagonism of the D2 dopamine receptor enhances tremor but reduces voluntary muscle activation in humans." Neuropharmacology 141 (2018): 343-352.

Bogers, Jan PAM, Peter FJ Schulte, Theo G. Broekman, Peter Moleman, and Lieuwe de Haan. "Dose reduction of high-dose first-generation antipsychotics or switch to ziprasidone in long-stay patients with schizophrenia: A 1-year double-blind randomized clinical trial." European Neuropsychopharmacology 28, no. 9 (2018): 1024-1034.

Cardoso, Daniel, Joseph Wakeham, Philippa Amy Shaw, Brittany Dutton, and Levine Wildman. "Chlorpromazine versus thiothixene for people with schizophrenia." The Cochrane Database of Systematic Reviews 2017, no. 9 (2017).

Prasad, Konasale M., Ashley M. Burgess, Matcheri S. Keshavan, Vishwajit L. Nimgaonkar, and Jeffrey A. Stanley. "Neuropil pruning in early-course schizophrenia: immunological, clinical, and neurocognitive correlates." Biological psychiatry: cognitive neuroscience and neuroimaging 1, no. 6 (2016): 528-538.

Hyatt, William S., Michael D. Berquist, Neha M. Chitre, Lauren N. Russell, Kenner C. Rice, Kevin S. Murnane, and William E. Fantegrossi. "Repeated administration of synthetic cathinone 3, 4-methylenedioxypyrovalerone persistently increases impulsive choice in rats." Behavioural pharmacology 30, no. 7 (2019): 555-565.

Lu, Justin Y., Arun K. Tiwari, Gwyneth C. Zai, Anjali Rastogi, Sajid A. Shaikh, Daniel J. Müller, Aristotle N. Voineskos et al. "Association study of Disrupted-In-Schizophrenia-1 gene variants and tardive dyskinesia." Neuroscience letters 686 (2018): 17-22.

Duart-Castells, Leticia, Raúl López-Arnau, Sonia Vizcaíno, J. Camarasa, D. Pubill, and E. Escubedo. "7, 8-Dihydroxyflavone blocks the development of behavioral sensitization to MDPV, but not to cocaine: Differential role of the BDNF-TrkB pathway." Biochemical pharmacology 163 (2019): 84-93.

Fekih-Romdhane, Feten, Leila Chennoufi, and Mejda Cheour. "La schizophrénie dans le DSM-5." In Annales Médico-psychologiques, revue psychiatrique, vol. 174, no. 8, pp. 672-676. Elsevier Masson, 2016.

Beckmann, David, Kelsey Leigh Lowman, Jessica Nargiso, James McKowen, Lisa Watt, and Amy M. Yule. "Substance-induced psychosis in youth." Child and Adolescent Psychiatric Clinics 29, no. 1 (2020): 131-143.

Giovanni, Andrew, Joachim Roehr, Shannon Dwyer, Kent Neuenschwander, Anthony Scotese, Neil D. Moorcroft, Larry Davis, and Zhongli Gao. "Design and synthesis of D1 agonist/D2 antagonist for treatment of schizophrenia." Bioorganic & medicinal chemistry letters 23, no. 5 (2013): 1498-1501.

Shokry, Ibrahim M., Vikash Sinha, Guilherme Da Silva, Sol-be Park, John J. Callanan, and Rui Tao. "Comparison of electroencephalogram (EEG) response to MDPV versus the hallucinogenic drugs MK-801 and ketamine in rats." Experimental neurology 313 (2019): 26-36.

Chacko, Mason, Asha Job, Fred Caston, Prem George, Adeeb Yacoub, and Ricardo Cáceda. "COVID-19-induced psychosis and suicidal behavior: case Report." SN Comprehensive Clinical Medicine 2, no. 11 (2020): 2391-2395.

Pieprzyca, Ewelina, Rafa? Skowronek, ?uboš Nižnanský, and Piotr Czekaj. "Synthetic cathinones–From natural plant stimulant to new drug of abuse." European journal of pharmacology 875 (2020): 173012.

Betti, Andresa H., Camila B. Antonio, Thais ET Pompeu, Thaise S. Martins, Vivian Herzfeldt, Eveline D. Stolz, Carlos AM Fraga, Eliezer Barreiro, François Noël, and Stela MK Rates. "LASSBio-1422: a new molecular scaffold with efficacy in animal models of schizophrenia and disorders of attention and cognition." Behavioural pharmacology 28, no. 1 (2017): 48-62.

Zhuo, Chuanjun, Langlang Cheng, Gongying Li, Yong Xu, Rixing Jing, Shen Li, Li Zhang, Xiaodong Lin, and Chunhua Zhou. "COMT-Val158Met polymorphism modulates antipsychotic effects on auditory verbal hallucinations and temporal lobe gray matter volumes in healthy individuals—symptom relief accompanied by worrisome volume reductions." Brain imaging and behavior 14, no. 5 (2020): 1373-1381.

Fratantonio, James, Lawrence Andrade, and Marcelo Febo. "Designer drugs: a synthetic catastrophe." Journal of reward deficiency syndrome 1, no. 2 (2015): 82.

Micoulaud-Franchi, Jean-Arthur, Mélanie Faugere, Laurent Boyer, Michel Cermolacce, Guillaume Fond, Raphaëlle Richieri, Jean Vion-Dury, and Christophe Lancon. "Sensory gating deficits and impaired quality of life in patients with schizophrenia: A preliminary study." Psychiatria Danubina 28, no. 3 (2016): 225-233.